HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Berkel, M. E. A. T. Articles by Oosterwegel, M. A. Search for Related Content PubMed PubMed Citation Articles by van Berkel, M. E. A. T. Articles by Oosterwegel, M. A. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH

ICOS Contributes to T Cell Expansion in CTLA-4 Deficient Mice¹

Miranda E. A. T. van Berkel^*, Elise H. R. Schrijver^*, Frans M. A. Hofhuis^*, Arlene H. Sharpe, Anthony J. Coyle, Chris P. Broeren, Kiki Tesselaar^* and Mariëtte A. Oosterwegel^2,*

^* Department of Immunology, University Medical Center, Utrecht, The Netherlands; Department of Pathology, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA 02115; Millennium Pharmaceuticals Inc., Cambridge, MA 02139; and University of Utrecht, Institute of Infectious Diseases and Immunology, Utrecht, The Netherlands

Both CD28 and ICOS are important costimulatory molecules that promote Ag-specific cellular and humoral immune reactions. Whereas CD28 is generally thought to be the most important molecule in the initiation of a T cell response, ICOS is considered to act during the effector phase. We have investigated the contribution of ICOS to T cell responses in the absence of CTLA-4-mediated inhibition. Mice lacking CTLA-4, which show spontaneous CD28-mediated CD4⁺ T cell activation, expansion and differentiation, were treated with antagonistic ICOS antibodies. Blocking the interaction between ICOS and its ligand B7RP-1 significantly reduced this aberrant T cell activation and caused a reduction in T cell numbers. In vitro analysis of CD4⁺ T cells from treated mice revealed that ICOS blockade significantly reduced Th1 differentiation, while Th2 differentiation was only moderately inhibited. Further in vitro stimulation experiments demonstrated that ICOS is able to induce proliferation of murine CD4⁺ and CD8⁺ T cells but only in the presence of IL-2. These results indicate that ICOS is not only important for T cell effector function but also contributes to the expansion phase of a T cell response in the presence of CD28 signaling.

This article has been cited by other articles:

				H. Lu, B. L. F. Kaplan, T. Ngaotepprutaram, and N. E. Kaminski Suppression of T cell costimulator ICOS by {Delta}9-tetrahydrocannabinol J. Leukoc. Biol., February 1, 2009; 85(2): 322 - 329. [Abstract] [Full Text] [PDF]

				O. Akbari, P. Stock, E. H. Meyer, G. J. Freeman, A. H. Sharpe, D. T. Umetsu, and R. H. DeKruyff ICOS/ICOSL Interaction Is Required for CD4+ Invariant NKT Cell Function and Homeostatic Survival J. Immunol., April 15, 2008; 180(8): 5448 - 5456. [Abstract] [Full Text] [PDF]

				E. H. Wilson, C. Zaph, M. Mohrs, A. Welcher, J. Siu, D. Artis, and C. A. Hunter B7RP-1-ICOS Interactions Are Required for Optimal Infection-Induced Expansion of CD4+ Th1 and Th2 Responses J. Immunol., August 15, 2006; 177(4): 2365 - 2372. [Abstract] [Full Text] [PDF]